Menu

Help your patients utilize their time while infusing

Infusing FEIBA [Anti-Inhibitor Coagulant Complex] with a syringe pump helps your patients control the infusion rate and provides a hands-free experience.1

Maximum injection or infusion rate must not exceed 2 units per kg of body weight per minute.

FEIBA is available in 3 dosage strengths1,*

Color-coded boxes and vial labels make it easy to identify each dose level.

FEIBA comes with a suitable volume (10 mL, 20 mL, or 50 mL) of Sterile Water for Injection.

Room temperature storage1

  • Store at room temperature. Do not exceed 25°C (77°F)
  • Store FEIBA [Anti-Inhibitor Coagulant Complex] in its original package to protect it from light
  • Avoid freezing, which may damage the diluent vial

BAXJECT® II Hi-Flow Needleless Transfer Device for easy mixing

To make reconstitution safe, fast, and easy,* FEIBA comes packaged with the BAXJECT II Hi-Flow Needleless Transfer Device. Reconstitution with the BAXJECT II Hi-Flow device requires fewer steps than the previous BAXJECT device, and it is color-coded for more intuitive reconstitution.1,4

  1. Connect the diluent vial
  2. Connect the FEIBA vial
  3. Withdraw mixed FEIBA
*As compared to needles, the BAXJECT II Hi-Flow device is needleless and has a one-piece design.

BAXJECT II Hi-Flow Product Information

Rx only. For safe and proper use of this device, please refer to the Instructions for Use in the FEIBA full Prescribing Information.

NOTE: The BAXJECT II Hi-Flow device should be used only with FEIBA.

The BAXJECT II Hi-flow device is intended for use with a single vial of product and is for single use only. Therefore, reconstitution and withdrawing a second vial into the syringe requires a second BAXJECT II Hi-flow device.

For detailed step-by-step instructions for reconstituting FEIBA with BAXJECT II Hi-Flow device, download the Instructions for Use.

Dosing Guidelines

The FEIBA Guidelines for Dosing is an educational guide for healthcare professionals only.

Learn More

Efficacy and Safety Data

Find out how FEIBA helped patients with hemophilia A or B with inhibitors in a clinical trial.

See the Data
See LessMore

Indications for Feiba

FEIBA is an Anti-Inhibitor Coagulant Complex indicated for use in hemophilia A and B patients with inhibitors for:

  • Control and prevention of bleeding episodes

Detailed Important Risk Information

WARNING: EMBOLIC AND THROMBOTIC EVENTS

  • Thromboembolic events have been reported during post-marketing surveillance following infusion of FEIBA,

Indications for Feiba

FEIBA is an Anti-Inhibitor Coagulant Complex indicated for use in
hemophilia A and B patients with inhibitors for:

  • Control and prevention of bleeding episodes
  • Perioperative management
  • Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.

FEIBA is not indicated for the treatment of bleeding episodes resulting from...

Detailed Important Risk Information

WARNING: EMBOLIC AND THROMBOTIC EVENTS

  • Thromboembolic events have been reported during post-marketing surveillance following infusion of FEIBA, particularly following the administration of high doses (above 200 units per kg per day) and/or in patients with thrombotic risk factors.
  • Monitor patients receiving FEIBA for signs and symptoms of thromboembolic events.
;